Details of the Drug

General Information of Drug (ID: DMTG9EV)

Drug Name

ATRC-101

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Polyadenylate-binding protein 1 (PABPC1)	TTHC8EF	PABP1_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04244552) A Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Atreca.